Congenital cytomegalovirus infection: current strategies and future perspective

Medicine and Dentistry

• Therapeutic Procedure 100%
• Congenital Cytomegalovirus Infection 80%
• Child 60%
• Childbirth 60%
• Valganciclovir 40%
• Ganciclovir 40%
• Neonatal Infant 40%
• Follow up 20%
• Newborn Period 20%
• Morbidity 20%
• Cohort Effect 20%
• Infection 20%
• Diagnosis 20%
• Development 20%
• Sequela 20%
• Sensorineural Hearing Loss 20%
• Drug 20%
• Cytomegalovirus 20%
• Chemotherapeutic Agent 20%
• Congenital Infection 20%
• Subclinical Infection 20%
• Infant 20%
• Childhood 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Valganciclovir 40%
• Ganciclovir 40%
• Human 20%
• Prognosis 20%
• Infection 20%
• Epidemiology 20%
• Morbidity 20%
• Drug 20%
• Cytomegalovirus 20%
• Perception Deafness 20%
• Asymptomatic Infection 20%
• Congenital Infection 20%